Induction of human gamma interferon by structurally defined polypeptide fragments of group A streptococcal M protein. 1984

D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron

The presence of interferon (IFN) has been demonstrated previously (i) in fluids obtained from the middle ears of children with Streptococcus pneumoniae infections, (ii) from the serum of mice injected intraperitoneally with either S. pneumoniae or Streptococcus pyogenes, and (iii) from human lymphoid cell cultures treated with a variety of bacteria. In this study, we showed that highly purified peptic extracts of three different serotypes of group A streptococcal M protein (pep M5, pep M6, and pep M24) stimulated human peripheral leukocytes to produce IFN. IFN production was apparent by 10 h and peaked 24 h after exposure. Dose-response experiments indicated that IFN could be detected in cultures treated with concentrations of M protein as low as 6 micrograms/ml, whereas maximum IFN production occurred at a concentration of 200 micrograms/ml. The IFN had antigenic and physicochemical characteristics of IFN-gamma. Preliminary leukocyte fractionation studies revealed that the IFN-producing cell was a nonadherent lymphocyte with receptors for sheep erythrocytes (T cell). Rabbit antisera specific for these structurally defined polypeptide fragments of streptococcal M protein (pep M5, pep M6, and pep M24) blocked IFN induction by each of the polypeptides. The data suggest that the different serotypes of streptococcal M protein may induce IFN by a common structural determinant shared by each of the polypeptide fragments tested.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
April 1981, Journal of immunology (Baltimore, Md. : 1950),
D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
October 1979, The Journal of experimental medicine,
D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
January 1979, Transactions of the Association of American Physicians,
D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
April 1982, The Journal of experimental medicine,
D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
November 1982, Infection and immunity,
D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
January 1981, Journal of interferon research,
D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
January 1983, Natural immunity and cell growth regulation,
D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
July 2005, Journal of immunology (Baltimore, Md. : 1950),
D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
January 1985, Pediatric infectious disease,
D A Weigent, and E H Beachey, and T Huff, and J W Peterson, and G J Stanton, and S Baron
January 1999, Vaccine,
Copied contents to your clipboard!